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P U B L I S H E D B Y E L S E V I E R I N C .LettersPrevalence of Ideal
Cardiovascular Health
Among Adults in the
United StatesIn 2010, the American Heart Association set
2020 national goals for promoting cardiovascular
health (CVH), emphasizing measurement of repro-
ducible health behaviors and health factors and
attaining ideal CVH status (1). In this letter,
we describe the frequency of ideal status for indi-
vidual CVH metrics with a focus on presence of
ideal CVH.of Ideal Cardiovascular Metrics and Health Among Adults in the United
al,
r
Cohort
Recruitment
Age (yrs);
% Female Total (N) Smoking, % BMI, % A
iol, 1987–1989 54; 56% 12,744 72 35
, 2012 1987–1999 46; 24% 11,993 56 46
1988–1994 45; 52% 15,305 45 44
1993–2001 69; 64% 2,981 81 31
2014 1995–1998 58; 55% 2,680 NR NR
1997–2007 55; 17% 3,121 NR NR
1999–2002 43; 52% 7,622 78 34
Qual 2000–2002 62; 52% 5,805 86 29
2014 2000–2002 38; 52% 1,177 68 45
5 2000–2004 55; 63% 4,132 88 14
2001–2006 30–69; 59% 673 29 23
art 2002–2010 55; None 490 75 15
015 2002–2003 57; 59% 1,731 61 26
11 2003 59; 6% 1,933 47 19
013 2003–2007 65; 58% 22,914 84 25
2003–2008 $20; 49% 14,515 75 32
, 2009–2011 52; 58% 4,754 90 27
ol, 2015 2014 43; 74% 9,364 98 32
7 ideal factors or $11 points on a 14-point scale (each factor scored 0, 1, or 2 for poor, int
alth; NR ¼ not reported.The MEDLINE database was searched for studies
conducted in U.S. adults (age $18 years) between
January 2000 and June 2015. Studies without infor-
mation on individual metrics or numeric CVH index
were excluded. Ideal CVH was deﬁned as 6 to 7 ideal
factors or $11 points on a 14-point scale (each factor
scored 0, 1, or 2 for poor, intermediate, and ideal,
respectively).
Overall, 18 studies were included in this re-
view with 16 reported frequencies of individual
CVH metrics, whereas 15 had information on
ideal CVH categorization (Table 1). Across varying
population cohorts studied from 1987 to 2014 in
the United States, the diet metric consistently
appeared suboptimal with 10 of 16 (63%) studies
reporting ideal proportions of #5%. None of theStates
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1634studies reported ideal body mass index or blood
pressure metrics >50%. Presence of ideal status
>50% was noted in 13 of 18 (81%) for smoking
and blood glucose metrics, respectively. Overall,
ideal CVH was very low ranging from 1% to
12% with 11 of 15 (73%) studies reporting #5%
prevalence.
There is convincing evidence that ideal CVH, as
described in the American Heart Association 2020
goal, protects from cardiovascular and all-cause
mortality. Lack of substantial change in ideal CVH
status over the last 2 decades and a projected 6%
improvement by 2020 underscores emergent need for
coordinated efforts to maximize gains in near-term
for sustainable impact (1). The results of our ﬁnd-
ings show that metrics most likely to achieve the
highest yield are healthy diet and physical activity
because they are noted to be least prevalent uni-
formly across all cohorts studied in the United States.
Systematic efforts focusing on these targets will likely
accelerate achieving ideal CVH goals by also indi-
rectly inﬂuencing attainment of favorable status for
body mass index, blood pressure, and fasting glucose
metrics.Adnan Younus, MD
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Counter Improvements in
Cardiovascular Risk Factor
Management in
Coronary PatientsThree EUROASPIRE (EUROpean Action on Secondary
and Primary prevention In order to Reduce Events)
surveys, conducted between 1999 and 2013 in
Belgium, Czech Republic, Finland, France, Ireland,
the Netherlands, Poland, Slovenia, and United
Kingdom, sought to describe in coronary patients
time trends in lifestyle, risk factor control including
management of diabetes, and cardioprotective med-
ications (1,2). They were undertaken in the same
geographic areas and hospitals including $1 hospital,
offering interventional cardiology and cardiac sur-
gery. Consecutive patients with coronary disease
($18 to <70 years of age) were identiﬁed from hos-
pital discharge lists: 1) coronary artery bypass graft-
ing; 2) percutaneous coronary intervention; 3) acute
myocardial infarction; and 4) unstable angina were
interviewed and examined $6 months later. A
centralized training base of data collectors and stan-
dardized methodologies, including central laboratory
measurements, ensured data quality.
Of 12,775 identiﬁed patients, 8,456 were inter-
viewed (66.2%): 3,320 patients in EUROASPIRE II (1999
to 2000), 2,632 in EUROASPIRE III (2006 to 2007), and
2,513 in EUROASPIRE IV (2012 to 2013). Interview rates
were 67.5%, 63.6%, and 51.4%, respectively. A com-
parison of those attending with those who did not
showed lower participation in women, in younger pa-
tients (except EUROASPIRE II), and those not revas-
cularized. The time trends in lifestyle, medical risk
factors, and prescriptions for cardioprotective medi-
cations are presented in Figures 1A and 1B. The pro-
portion of persistent smokers was similar (52%, 55%,
53%; p ¼ 0.67), whereas obesity (32%, 33%, 39%;
p ¼ 0.007) and self-reported diabetes (19%, 24%, 27%;
p ¼ 0.004) increased. The prevalence of raised blood
pressure ($140/90 mm Hg or $140/80 mm Hg with
diabetes; 54%, 52%, 45%; p ¼ 0.01) and raised low-
density lipoprotein (LDL)-cholesterol ($1.8 mmol/l)
decreased (96%, 80%, 75%; p <0.0001). The use of
high-intensity statins (atorvastatin, 40 to 80 mg, or
rosuvastatin, 20 to 40 mg, or simvastatin, 80 mg)
increased (in EUROASPIRE III to IV 23.0% to 45.1%).
The comparison among 3 surveys over 14 years pro-
vides a unique description of time trends for secondary
prevention. They reveal stagnation in the prevalence
